VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+11.92%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$191M
AUM Growth
-$59.3M
(-24%)
Cap. Flow
-$77.9M
Cap. Flow
% of AUM
-40.7%
Top 10 Holdings %
Top 10 Hldgs %
5.8%
Holding
489
New
53
Increased
164
Reduced
226
Closed
46
Top Buys
| 1 |
D.R. Horton
DHI
|
$987K |
| 2 |
Lennar Class A
LEN
|
$952K |
| 3 |
Freeport-McMoran
FCX
|
$917K |
| 4 |
TJX Companies
TJX
|
$909K |
| 5 |
Ametek
AME
|
$905K |
Top Sells
| 1 |
Steel Dynamics
STLD
|
$1.65M |
| 2 |
NOA
North American Construction
NOA
|
$1.55M |
| 3 |
Alamos Gold
AGI
|
$1.53M |
| 4 |
Cheniere Energy
CQP
|
$1.51M |
| 5 |
GTY
Getty Realty Corp
GTY
|
$1.5M |
Sector Composition
| 1 | Healthcare | 26.88% |
| 2 | Financials | 12.6% |
| 3 | Technology | 10.15% |
| 4 | Materials | 9.55% |
| 5 | Real Estate | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
SL Green Realty
SLG
$4.4B
| $336K | 0.18% |
9,953
-22,501
| -69% | -$759K |
|
227
Roivant Sciences
ROIV
$8.82B
| $335K | 0.17% |
41,905
-21,151
| -34% | -$169K |
|
228
Horizon Technology Finance
HRZN
$294M
| $335K | 0.17% |
28,847
-8,382
| -23% | -$97.2K |
|
|
PHD
229
Pioneer Floating Rate Fund
PHD
$123M
| $333K | 0.17% |
37,951
-4,257
| -10% | -$37.3K |
|
230
Prospect Capital
PSEC
$1.34B
| $331K | 0.17% |
47,348
-10,592
| -18% | -$74K |
|
231
Sixth Street Specialty
TSLX
$2.32B
| $329K | 0.17% |
18,492
-4,244
| -19% | -$75.5K |
|
232
Petrobras
PBR
$78.7B
| $329K | 0.17% |
30,890
-102,769
| -77% | -$1.09M |
|
233
NRG Energy
NRG
$28.6B
| $329K | 0.17% |
10,330
-31,627
| -75% | -$1.01M |
|
|
PRVB
234
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $329K | 0.17% |
+31,095
| New | +$329K |
|
235
Mirum Pharmaceuticals
MIRM
$3.82B
| $327K | 0.17% |
16,790
+4,472
| +36% | +$87.2K |
|
236
Alico
ALCO
$256M
| $323K | 0.17% |
13,544
-26,382
| -66% | -$630K |
|
|
PNNT
237
Pennant Park Investment Corp
PNNT
$471M
| $323K | 0.17% |
56,113
-10,866
| -16% | -$62.5K |
|
|
NSL
238
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $322K | 0.17% |
70,201
-8,963
| -11% | -$41.1K |
|
239
Stellus Capital Investment Corp
SCM
$421M
| $320K | 0.17% |
24,149
-8,044
| -25% | -$107K |
|
240
ADMA Biologics
ADMA
$4.03B
| $320K | 0.17% |
+82,439
| New | +$320K |
|
241
Ares Capital
ARCC
$15.8B
| $319K | 0.17% |
17,264
-3,314
| -16% | -$61.2K |
|
|
ONC
242
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $318K | 0.17% |
1,446
-335
| -19% | -$73.7K |
|
243
Enanta Pharmaceuticals
ENTA
$189M
| $316K | 0.17% |
6,800
+917
| +16% | +$42.7K |
|
244
Ligand Pharmaceuticals
LGND
$3.25B
| $315K | 0.16% |
4,721
-327
| -6% | -$21.8K |
|
|
JRO
245
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $313K | 0.16% |
40,057
-4,634
| -10% | -$36.2K |
|
|
DCPH
246
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $312K | 0.16% |
19,052
-2,692
| -12% | -$44.1K |
|
247
BioCryst Pharmaceuticals
BCRX
$1.74B
| $311K | 0.16% |
27,086
+2,166
| +9% | +$24.9K |
|
248
Nuveen Floating Rate Income Fund
JFR
$1.13B
| $310K | 0.16% |
39,200
-4,478
| -10% | -$35.5K |
|
249
Sarepta Therapeutics
SRPT
$1.96B
| $310K | 0.16% |
2,395
-1,258
| -34% | -$163K |
|
|
CTIC
250
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $310K | 0.16% |
51,542
+8,172
| +19% | +$49.1K |
|